Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Core Laboratories Inc. (NYSE: CLB)
CLB Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
36.90%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
-10.20%
CLB Stock Analysis
CLB
PE Ratio:
21.2
CLB
PEG Ratio:
0.7
CLB
Forward EPS Growth (12 month):
31.30%
CLB
PS Ratio:
1.2
CLB
PSG Ratio:
0.2
CLB
Forward Revenue Growth (12 month):
4.80%
CLB Articles
No data was found